Skip to main content
Caplight Logo









National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of Diabetes and Digestive and Kidney Diseases

Bethesda, Marylandnih.gov

Overview

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is an institute within the U.S. National Institutes of Health that conducts and supports medical research and research training.

Year Founded

1986

Portfolio Companies

74

Website

nih.gov

Investments

National Institute of Diabetes and Digestive and Kidney Diseases investments
CompanyDateStageLead
Syntis Bio, Inc.Jul 2025GrantCo-investor
TYBR HealthAug 2021GrantCo-investor
Sharklet TechnologiesJul 2017GrantCo-investor
Diapin TherapeuticsDec 2015GrantCo-investor
HepaTx CorporationMay 2025GrantCo-investor
Book a demo to see all 74 portfolio companies

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is National Institute of Diabetes and Digestive and Kidney Diseases based?

National Institute of Diabetes and Digestive and Kidney Diseases is headquartered in Bethesda, Maryland, United States.

When was National Institute of Diabetes and Digestive and Kidney Diseases founded?

National Institute of Diabetes and Digestive and Kidney Diseases was founded in 1986.

How many portfolio companies does National Institute of Diabetes and Digestive and Kidney Diseases have?

National Institute of Diabetes and Digestive and Kidney Diseases has 74 portfolio companies in Caplight's dataset.

What are some companies in National Institute of Diabetes and Digestive and Kidney Diseases's portfolio?

Portfolio companies visible on Caplight include Syntis Bio, Inc., TYBR Health, Sharklet Technologies, Diapin Therapeutics, HepaTx Corporation.

What was National Institute of Diabetes and Digestive and Kidney Diseases's most recent investment shown here?

National Institute of Diabetes and Digestive and Kidney Diseases's most recent investment in this portfolio sample was in Syntis Bio, Inc. in 2025.

What sectors does National Institute of Diabetes and Digestive and Kidney Diseases focus on?

National Institute of Diabetes and Digestive and Kidney Diseases focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.

What company stages does National Institute of Diabetes and Digestive and Kidney Diseases focus on?

National Institute of Diabetes and Digestive and Kidney Diseases typically invests at the MultiStage stage.

Firmographic Details

HeadquartersBethesda, Maryland
Year Founded1986

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?